DE2144699A1 - Neue organische Verbindungen und Verfahren zu deren Herstellung - Google Patents
Neue organische Verbindungen und Verfahren zu deren HerstellungInfo
- Publication number
- DE2144699A1 DE2144699A1 DE19712144699 DE2144699A DE2144699A1 DE 2144699 A1 DE2144699 A1 DE 2144699A1 DE 19712144699 DE19712144699 DE 19712144699 DE 2144699 A DE2144699 A DE 2144699A DE 2144699 A1 DE2144699 A1 DE 2144699A1
- Authority
- DE
- Germany
- Prior art keywords
- group
- formula
- compounds
- hydrogen
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 10
- 238000004519 manufacturing process Methods 0.000 title description 2
- 150000002894 organic compounds Chemical class 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims description 27
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- 239000001257 hydrogen Substances 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 11
- 125000006239 protecting group Chemical group 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 125000002339 acetoacetyl group Chemical group O=C([*])C([H])([H])C(=O)C([H])([H])[H] 0.000 claims description 3
- 238000005903 acid hydrolysis reaction Methods 0.000 claims description 3
- 239000007795 chemical reaction product Substances 0.000 claims description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims 6
- 229940126601 medicinal product Drugs 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- WASQWSOJHCZDFK-UHFFFAOYSA-N diketene Chemical compound C=C1CC(=O)O1 WASQWSOJHCZDFK-UHFFFAOYSA-N 0.000 description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010067572 Oestrogenic effect Diseases 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 230000001076 estrogenic effect Effects 0.000 description 2
- 230000012173 estrus Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010030247 Oestrogen deficiency Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000001072 progestational effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7127970A | 1970-09-10 | 1970-09-10 | |
| US11408071A | 1971-02-09 | 1971-02-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2144699A1 true DE2144699A1 (de) | 1972-03-16 |
Family
ID=26752051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19712144699 Pending DE2144699A1 (de) | 1970-09-10 | 1971-09-07 | Neue organische Verbindungen und Verfahren zu deren Herstellung |
Country Status (7)
| Country | Link |
|---|---|
| AU (1) | AU3330971A (enExample) |
| BE (1) | BE772368A (enExample) |
| DE (1) | DE2144699A1 (enExample) |
| FR (1) | FR2106419B1 (enExample) |
| GB (1) | GB1364858A (enExample) |
| HU (1) | HU163032B (enExample) |
| NL (1) | NL7112010A (enExample) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE656362A (enExample) * | 1963-11-29 |
-
1971
- 1971-03-06 GB GB4144671*A patent/GB1364858A/en not_active Expired
- 1971-09-01 NL NL7112010A patent/NL7112010A/xx unknown
- 1971-09-07 DE DE19712144699 patent/DE2144699A1/de active Pending
- 1971-09-08 FR FR7132356A patent/FR2106419B1/fr not_active Expired
- 1971-09-08 BE BE772368A patent/BE772368A/xx unknown
- 1971-09-08 HU HUSA2239A patent/HU163032B/hu unknown
- 1971-09-09 AU AU33309/71A patent/AU3330971A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL7112010A (enExample) | 1972-03-14 |
| FR2106419B1 (enExample) | 1975-08-01 |
| BE772368A (fr) | 1972-03-08 |
| HU163032B (enExample) | 1973-05-28 |
| AU3330971A (en) | 1973-03-15 |
| GB1364858A (en) | 1974-08-29 |
| FR2106419A1 (enExample) | 1972-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2652391C3 (de) | Daunosaminylanthracyclinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2631885A1 (de) | Phenoxyderivate, verfahren zu ihrer herstellung und deren therapeutische verwendung | |
| DE2819216A1 (de) | Neue anthracyclinanaloga | |
| DE2144699A1 (de) | Neue organische Verbindungen und Verfahren zu deren Herstellung | |
| DE2822751A1 (de) | Cyclopentanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| DE69306303T2 (de) | Monoquaternäre 2,16-Bispiperidinglandrostanderivate | |
| DE2410853A1 (de) | Reinigung und trennung von steroidlactonen | |
| DE2106615A1 (de) | Verfahren zur Herstellung von Erythromycylamin-Verbindungen | |
| DE3200809A1 (de) | Anthracyclin-glycoside, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| DE2656574A1 (de) | Neue 1,6-naphthyridincarbonsaeurederivate und verfahren zu ihrer herstellung | |
| DE2119327A1 (de) | Neue Steroide sowie Verfahren zur Herstellung von Steroiden | |
| EP0080674B1 (de) | Neue Oxime von 3"'-Dehydro-cardenolid-tridigitoxosiden, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| DE2842495C2 (de) | 4-Cyclohexyl-α-niederalkyl-1-naphthalinessigsäure, deren pharmakologisch verträgliche Salze und Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
| DE2935684A1 (de) | 2-bromergosinin und seine saeureadditionssalze, verfahren zu deren herstellung sowie deren verwendung als arzneimittel | |
| DE1643007C3 (de) | 3-Chlor-Steroide | |
| AT253141B (de) | Verfahren zur Herstellung von neuen Steroiden | |
| AT281818B (de) | Verfahren zur herstellung neuer heterocyclischer verbindungen | |
| DE1793738C3 (de) | 3-0A-11 beta-OB-17alpha-R-17beta-OH-östra-1,3,5 (10)-trlene und diese enthaltende Arzneimittel | |
| DE1768416C3 (de) | 4-ChIor-7 a-methyl-4-androstenolone, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel | |
| DE2235646C3 (de) | Kalium- oder Natriumsalze der 3- (3-Oxo-17 ß-hydroxy-6,7 ß-methylen- androst-4-en-(oder -androsta-l,4-dien) -17 ct-yl)-propionsaure und Verfahren zu ihrer Herstellung | |
| AT226888B (de) | Verfahren zur Herstellung von Nordihydrotoxiferin und dessen Quaternisierungsprodukten | |
| CH555820A (de) | Verfahren zur herstellung neuer allenyl-carbinole. | |
| DE2028033A1 (enExample) | ||
| DE2109305B2 (de) | 20-Hydroxylierte 17 a - MethyI-19-nor-pregna-4,9diene, Verfahren zu deren Herstellung sowie Zwischenprodukte | |
| DE1917049A1 (de) | Neue organische Verbindungen und Verfahren zu ihrer Herstellung |